— THE MEMBER EXPERIENCE

Substantive. Collegial. Entirely on your terms.

We built EyeSci Angels around a simple belief: that early-stage ophthalmology investing is most rewarding when it is intellectually rigorous, genuinely collegial, and entirely on your terms. There are no capital deployment obligations and no pressure to invest in any deal simply because it was offered.

— DEAL FORUMS

Every company earns its place.

When a company enters our member-facing process, members are invited to a deal forum: a structured live presentation where founders engage directly with the community.

These sessions are substantive and interactive. Founders present to an audience of clinicians, scientists, operators, and professionals from a range of backgrounds, and the dialogue that follows is focused on what matters. The goal is clarity about the science, the opportunity, and the risks — not a sales pitch.

Members participate in the discussion at whatever level feels right for them.

Every company that reaches a deal forum has already cleared a rigorous multi-stage internal screening process. Our principals evaluate each opportunity on:

  • Clinical rationale and translatability

  • Founder credibility and team quality

  • Regulatory and reimbursement plausibility

  • Competitive positioning and IP strategy

By the time a company presents to the group, it has earned its place on the strength of its underlying evidence and overall investment case.

— EDUCATIONAL DISCUSSIONS

Build fluency in the space you know best.

We offer periodic educational discussions on the topics that matter most in ophthalmic angel investing. They are designed to build practical investing fluency over time — whether you are new to the asset class or simply enjoy the intellectual dimension of early-stage investing. These discussions are open to all members, including Observers, at no cost.

  • Clinical trial design in ophthalmology

  • Reimbursement pathways and payer dynamics in eye care

  • Intellectual property strategy and competitive positioning in ophthalmic innovation

  • Emerging technologies and therapeutic modalities

  • Regulatory strategy for ophthalmic devices and pharmaceuticals

  • Case-based review of early-stage investment decisions

— MORE WAYS TO ENGAGE

Beyond the deal forum.

Small-Group Dialogue

Members connect directly with founders and with each other in small-group settings that allow for focused, unhurried dialogue — direct access to management, space for detailed inquiry, and the opportunity to build relationships that extend well beyond any individual investment.

In-Person Gatherings

We bring members together at major national ophthalmology meetings and at curated member gatherings — intimate, peer-driven settings that strengthen relationships and extend the community well beyond any single deal or presentation.

Portfolio Updates

Members who invest receive periodic updates covering clinical, technical, regulatory, and financing progress. Deal leads maintain ongoing dialogue with portfolio companies and surface material developments as they arise. The goal is informed engagement, not passive ownership.

— OBSERVER MEMBERSHIP

Ready to see it for yourself?

The best way to understand what EyeSci Angels feels like is to be part of it. Observer Membership is free. Start there, and see where it takes you.

START AS AN OBSERVER

"EyeSci Angels is a community of colleagues who share a deep interest in early ophthalmic innovation and a belief that disciplined, evidence-based investing in this space is both intellectually rewarding and financially meaningful."

Members engage at their own pace and on their own terms.